Insilico’s AI-discovered ulcerative colitis drug starts Phase I trial

Insilico’s AI-discovered ulcerative colitis drug starts Phase I trial

Source: 
Clinical Trials Arena
snippet: 

After the healthy volunteer study, Insilico plans to conduct a Phase Ib trial in patients with ulcerative colitis (UC).